StockWatch
·

SAMRAT PHARMACHEM LTD.-$ Q1 FY27 Results

SAMRATPHQ1 FY27 Results
Filing
Result:Steady· Market: Up#Turnaround#Base effect
MetricValue ( Cr)Q4 FY26Q1 FY26
Revenue79.7611.1%5.4%
Total Income80.7513.0%5.8%
Expenditure79.167.9%4.0%
PBT1.59184.6%662.9%
Net Profit0.88143.0%482.7%
OPM1.13%2.86pp0.97pp
NPM1.08%3.93pp1.38pp
EPS2.8456.9%283.8%
View full financials

Revenue grew a modest 5.4% YoY and the swing to profit is a loss-to-profit turnaround off a near-zero base, with OPM/NPM still thin at ~1%, so it's an in-line quarter rather than a true standout despite the large PAT% growth.

Informational and educational content only. Not investment advice.